Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Autolus Therapeutics (AUTL) Accumulated Depreciation & Amortization (2017 - 2025)

Autolus Therapeutics' Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 9.82% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $8.3 million, up 9.82%, while the annual FY2025 figure was $8.3 million, 9.82% up from the prior year.
  • Accumulated Depreciation & Amortization reached $8.3 million in Q4 2025 per AUTL's latest filing, up from $6.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $8.5 million in Q4 2021 to a low of $1.8 million in Q1 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.2 million, with a median of $5.6 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 49.49% in 2021, then dropped 17.03% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $8.5 million in 2021, then dropped by 12.25% to $7.4 million in 2022, then fell by 11.55% to $6.6 million in 2023, then rose by 15.06% to $7.6 million in 2024, then rose by 9.82% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Accumulated Depreciation & Amortization are $8.3 million (Q4 2025), $6.2 million (Q3 2025), and $4.1 million (Q2 2025).